entertainment -WSS

entertainment

author：comprehensive 2025-09-06 08:24:57 - browse：16373

Illustration of three connected puzzle pieces, with a woman standing near the missing/empty puzzle piece space. -- first opinion coverage from STAT — Adobe

Women have always been underrepresented in medical research. A new study reveals that not much has changed, especially when it comes to tests of cardiovascular devices.

In a paper published in JAMA Internal Medicine on Monday, researchers found that the percentage of women represented in high-risk medical device trials did not increase from 2010 to 2020. Women generally made up just 33% of participants when the team reviewed 195 trials published from 2016 to 2022. The percentages varied between devices: Women made up 46% of participants in orthopedic trials, but 29% in cardiovascular studies.

The issue isn’t new. The government has made some strides in correcting earlier missteps, like the Food and Drug Administration telling researchers in 1977 to exclude women of reproductive potential from early clinical trials. But stakeholders think agencies like the FDA could do more to incentivize the enrollment of women.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： How generative AI is inspiring dreams of a health data revolution

WSS

The 10 drugs up first for Medicare price negotiation

A new House health package & hospitals’ new site

NIH nominee Bertagnolli will get October confirmation hearing

How generative AI is inspiring dreams of a health data revolution

Amazon on where the company's health care bets are headed next

Addressing health care workers' trauma can help fight burnout

explore

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

knowledge

Hepatitis C has a cure — but many Americans still lack access to it

ALS advocates say criticism of new drugs misses bigger picture

After affirmative action ruling, medical educators look to 'holistic review'

NIH nominee Bertagnolli will get October confirmation hearing

Affirmative action in medical school literally saved lives

At flashy new research hub, AstraZeneca lays out ambitious growth goals

Supreme Court strikes down use of affirmative action

UnitedHealth argues against case alleging wrongful AI care denials

FDA approval of Sarepta Duchenne genetic therapy gives me hope

UnitedHealth argues against case alleging wrongful AI care denials

leisure time

Addressing health care workers' trauma can help fight burnout

How to fix cancer clinical trials' diversity problem

Study finds gene variants tied to breast cancer risk in Black women

As a primary care physician, here's how I hope to partner with AI

Study finds gene variants tied to breast cancer risk in Black women

Citing H5N1 threat, CDC urges peak flu monitoring this summer

hotspot

leisure time

explore

explore